2m 2m 2m 2m 2m 2m 2m
ONKURE THERAP-A (OKUR)
NASDAQ
$4.15+$0.13 (+3.21%)
Price as of Aug 03, 2026 7:58 PM EDT- $154.3MMarket Cap
- 73.64%1-Year Change
- BiotechnologyIndustry
ONKURE THERAP-A (OKUR)
$4.15+$0.13 (+3.21%)
OKUR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.02 | ||
Change | -$0.18 (-4.50%) | ||
Open | $3.90 | ||
High | $4.08 | ||
Low | $3.75 | ||
Previous Close | $3.82 | ||
Volume | 160,231 | ||
30-Day Average Volume | 157,207 | ||
1-Week Change | -7.28% | ||
1-Month Change | -16.23% | ||
1-Year Change | 73.64% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 40.4M | ||
Total Assets | $198.7M | ||
Market Cap | $154.3M | ||
Enterprise Value | -$37.8M | ||
Period: QTR TTM FY | |||
Revenue | $458,000.00 | ||
Net Income | -$15.2M | ||
Free Cash Flow | -$12.9M | ||
EBIT | -$15.2M | ||
EBITDA | -$15.1M | ||
Net Working Capital | $183.2M | ||
EPS | -$1.11 | ||
Enterprise Value/EBITDA | 3 | ||
Enterprise Value/Revenue | -83 | ||
P/B | 1 | ||
P/E | -3 | ||
PEG | 0 | ||
Price/Free Cash Flow | -12 | ||
Price/Operating Cash Flow | -12 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue